Citation
Select
Fox KM, EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators,
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).
Lancet. 2003 Sep 6;362(9386):782-8
Citation
Select
Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J; CHARM Investigators and Committees
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial
Lancet. 2003 Sep 6;362(9386):777-81
Citation
Select
Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K; CHARM Investigators and Committees
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial
Lancet. 2003 Sep 6;362(9386):772-6
Citation
Select
McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL, Olofsson B, Yusuf S, Pfeffer MA; CHARM Investigators and Committees
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
Lancet. 2003 Sep 6;362(9386):767-71
Citation
Select
Barr RG, Rowe BH, Camargo CA Jr
Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials
BMJ. 2003 Sep 20;327(7416):643
Citation
Select
Lara LF, Cisneros G, Gurney M, Van Ness M, Jarjoura D, Moauro B, Polen A, Rutecki G, Whittier F
One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection
Arch Intern Med. 2003 Sep 22;163(17):2079-84